In the last trading session, 1,415,025 AIkido Pharma Inc. (NASDAQ:AIKI) shares changed hands as the company’s beta touched 1.58. With the company’s per share price at $0.97 changed hands at -$0.04 or -0.04% during last session, the market valuation stood at $86.73 Million. AIKI’s last price was a discount, traded about -162.89% off its 52-week high of $2.55. The share price had its 52-week low at $0.47, which suggests the last value was 51.55% up since then. When we look at AIkido Pharma Inc.’s average trading volume, we note the 10-day average is 2.05 Million shares, with the 3-month average coming to 4.35 Million.
Analysts gave the AIkido Pharma Inc. (AIKI) stock a consensus recommendation rating of 0, calculated at a mean rating of 0. If we narrow down to specifics, the data shows that none out of 0 analysts rate the stock as a Sell, with a further none assigning it an Overweight rating. Of the remaining, none recommended AIKI as a Hold, none felt it is a Buy and none rated the stock as Underweight. AIkido Pharma Inc.’s EPS for the current quarter is expected to be $0.
AIkido Pharma Inc. (NASDAQ:AIKI) trade information
Although AIKI has turned red as seen at the end of in last trading. With action -4.09%, the performance over the past five days has been red. The jump to weekly highs of $1.11 on Monday, Jun 14 added 12.73% to the stock’s daily price. The company’s shares are showing year-to-date upside of 0.11%, with the 5-day performance at -0.11% in the red. However, in the 30-day time frame, AIkido Pharma Inc. (NASDAQ:AIKI) is -0.09% down. Looking at the short shares, we see there were 262.65 Million shares sold at short interest cover period of 60.38 days.
The consensus price target for the stock as assigned by Wall Street analysts is $1802.25, meaning bulls need an upside of 185699% from its current market value. According to analyst projections, AIKI’s forecast low is $1802.25 with $1802.25 as the target high. To hit the forecast high, the stock’s price needs a +185699% upsurge from its current level, while the stock would need to tank 185699% for it to hit the projected low.
AIkido Pharma Inc. (AIKI) estimates and forecasts
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 66.6%. The 2021 estimates are for AIkido Pharma Inc. earnings to increase by 73.6%, but the outlook for the next 5-year period is at 0% per year.
AIkido Pharma Inc. (NASDAQ:AIKI)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.06% of AIkido Pharma Inc. shares while 16% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 16.01%. There are 21 institutions holding the AIkido Pharma Inc. stock share, with Vanguard Group, Inc. (The) the top institutional holder. As of Mar 30, 2021, the company held 4.84% of the shares, roughly 4.33 Million AIKI shares worth $4.94 Million.
Blackrock Inc. holds the second largest percentage of outstanding shares, with 1.72% or 1.54 Million shares worth $1.76 Million as of Mar 30, 2021.
Among Mutual Funds, the top two as of Mar 30, 2021 were Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. With 2683200 shares estimated at $3.06 Million under it, the former controlled 3% of total outstanding shares. On the other hand, Vanguard Extended Market Index Fund held about 1.7% of the shares, roughly 1.52 Million shares worth around $1.74 Million.